Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62021TN0644

    Case T-644/21: Action brought on 4 October 2021 — Pharmadom v EUIPO — Wellbe Pharmaceuticals (WellBe PHARMACEUTICALS)

    OJ C 37, 24.1.2022, p. 35–35 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    Date of document:
    04/10/2021
    Date lodged:
    04/10/2021
    Author:
    General Court
    Form:
    Judicial information
    Authentic language:
    English
    Type of procedure:
    Action for annulment
    Defendant:
    European Union Intellectual Property Office
    Link
    Select all documents mentioning this document
    Instruments cited in case law:
    Link

    24.1.2022   

    EN

    Official Journal of the European Union

    C 37/35

    Action brought on 4 October 2021 — Pharmadom v EUIPO — Wellbe Pharmaceuticals (WellBe PHARMACEUTICALS)

    (Case T-644/21)

    (2022/C 37/48)

    Language of the case: English

    Parties

    Applicant: Pharmadom (Boulogne-Billancourt, France) (represented by: M-P. Dauquaire, lawyer)

    Defendant: European Union Intellectual Property Office (EUIPO)

    Other party to the proceedings before the Board of Appeal: Wellbe Pharmaceuticals S.A. (Warsaw, Poland)

    Details of the proceedings before EUIPO

    Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal

    Trade mark at issue: Application for European Union figurative mark WellBe PHARMACEUTICALS — Application for registration No 17 151 176

    Procedure before EUIPO: Opposition proceedings

    Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 12 July 2021 in Case R 1423/2020-5

    Form of order sought

    The applicant claims that the Court should:

    —

    annul the contested decision.

    Plea in law

    Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

    Top